Comparison of the latest guideline and consensus about venous occlusive diseases_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

SHI Zhenyu ¹ ,  WU Danming ²

1. Division of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China;
2. Division of Vascular Surgery, Liaoning Province People Hospital, Shenyang 110000, P. R. China;

Corresponding author：

WU Danming, Email: danming_w@126.com

Keywords：

deep vein thrombosis; iliac vein compression syndrome; post thrombotic syndrome; guideline; consensus

DOI：

10.7507/1007-9424.202304038

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Venous occlusive diseases include acute deep vein thrombosis, as well as chronic iliac vein compression syndrome and post thrombotic syndrome. These diseases can lead to severe venous hypertension which greatly affect life quality. So domestic and international vascular society both have published several guidelines and consensus focusing on these diseases including the “Diagnosis and Treatment Standard about Common Venous Diseases 2022” by Vein Group of Vascular Surgery Committee from Chinese Medical Doctor Association, “2021 Clinical Practice Guidelines on the Management of Venous Thrombosis” and “2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs” by European Society of Vascular Surgery. Herein, we make a comparison and explanation of these guidelines and consensus to provide reference to the management of venous occlusive diseases.

Citation： SHI Zhenyu, WU Danming. Comparison of the latest guideline and consensus about venous occlusive diseases. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(5): 529-533. doi: 10.7507/1007-9424.202304038 Copy

1.	中国医师协会血管外科医师分会静脉学组. 常见静脉疾病诊治规范 (2022年版). 中华普通外科学文献 (电子版), 2022, 16(4): 255-272.
2.	Kakkos SK, Gohel M, Baekgaard N, et al. European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg, 2021, 61(1): 9-82.
3.	De Maeseneer MG, Kakkos SK, Aherne T, et al. European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg, 2022, 63(2): 184-267.
4.	Amin EE, Bistervels IM, Meijer K, et al. Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood, 2018, 132(21): 2298-2304.
5.	Male C, Lensing AWA, Palumbo JS, et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol, 2020, 7(1): e18-e27.
6.	Mahnken AH, Thomson K, de Haan M, et al. CIRSE standards of practice guidelines on iliocaval stenting. Cardiovasc Intervent Radiol, 2014, 37(4): 889-897.
7.	Masuda E, Ozsvath K, Vossler J, et al. The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology. J Vasc Surg Venous Lymphat Disord, 2020, 8(4): 505-525.e4.
8.	Milinis K, Thapar A, Shalhoub J, et al. Antithrombotic Therapy Following Venous Stenting: International Delphi Consensus. Eur J Vasc Endovasc Surg, 2018, 55(4): 537-544.

1. 中国医师协会血管外科医师分会静脉学组. 常见静脉疾病诊治规范 (2022年版). 中华普通外科学文献 (电子版), 2022, 16(4): 255-272.
2. Kakkos SK, Gohel M, Baekgaard N, et al. European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg, 2021, 61(1): 9-82.
3. De Maeseneer MG, Kakkos SK, Aherne T, et al. European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg, 2022, 63(2): 184-267.
4. Amin EE, Bistervels IM, Meijer K, et al. Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood, 2018, 132(21): 2298-2304.
5. Male C, Lensing AWA, Palumbo JS, et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol, 2020, 7(1): e18-e27.
6. Mahnken AH, Thomson K, de Haan M, et al. CIRSE standards of practice guidelines on iliocaval stenting. Cardiovasc Intervent Radiol, 2014, 37(4): 889-897.
7. Masuda E, Ozsvath K, Vossler J, et al. The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology. J Vasc Surg Venous Lymphat Disord, 2020, 8(4): 505-525.e4.
8. Milinis K, Thapar A, Shalhoub J, et al. Antithrombotic Therapy Following Venous Stenting: International Delphi Consensus. Eur J Vasc Endovasc Surg, 2018, 55(4): 537-544.

Previous Article
Research hotspots of venous surgery
Next Article
Guidelines interpretation of the ISTH guidelines for antithrombotic treatment in COVID-19

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Comparison of the latest guideline and consensus about venous occlusive diseases

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content